手机看黄色大片1024,亚洲v无码一区二区三区四区观看,黄真人在线观看高清无码,极品嫩模大尺度av在线播放免费观看

產品資料

AT3B-1細胞

如果您對該產品感興趣的話,可以
產品名稱: AT3B-1細胞
產品型號: AT3B-1
產品展商: HZbscience
產品文檔: 無相關文檔

簡單介紹

AT3B-1細胞應如何避免細胞污染,細胞污染的種類可分成**、酵母菌、霉菌、病毒和霉漿菌。主要的污染原因為無菌操作技術不當、操作室環境不佳、污染之血清和污染之細胞等。嚴格之無菌操作技術、清潔的環境、與品質良好之細胞來源和培養基配制是減低污染之*好方法。AT3B-1細胞何時須更換培養基?視細胞生長密度而定,或遵照細胞株基本數據上之更換時間,按時更換培養基即可。


AT3B-1細胞  的詳細介紹

AT3B-1細胞

器官來源: 前列腺

細胞形態: 上皮樣

是否是腫瘤細胞: 0

物種來源: 褐鼠

年限: 22 months

運輸方式: 凍存運輸

數量: 大量

品系: Copenhagen

ATCC Number: CRL-2375?

AT3B-1細胞相關**: 其他**

Designations: AT3B-1

Depositors: KJ Pienta

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Organism: Rattus norvegicus deposited as rat

Morphology: epithelial


Source: Organ: prostate

Strain: Copenhagen

Disease: AT3B-1細胞malignant carcinoma

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Age: 22 months

Gender: male

Comments: AT3B-1 was derived from the AT-3 cell line. AT-3 was derived from a ***** malignant rat prostate tumor obtained from a 22 month old inbred Copenhagen rat by Isaacs et al. [39920]

The parental cells were grown in increasing concentrations of the drug doxorubicin until the final concentration of 0.001 mM was achieved.

These cells express a multidrug (MDR) resistant phenotype. They are more resistant to vinblastine compared to controls.

When P-glycoprotein was blocked, the AT3 B-1 cell line demonstrated drug efflux pump activity. Injection of AT3 B-1 cells into rats followed by doxorubicin treatment produced larger tumors compared to the parental controls. [39921]

AT3B-1細胞This cell line can be used to study chemotherapy resistance in prostate cancer.

Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 0.001 mM doxorubicin, 90%; fetal bovine serum, 10%

Temperature: 37.0°C

Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.

Add fresh culture medium, aspirate and dispense into new culture flasks.

Preservation: Culture medium, 95%; DMSO, 5%

Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

recommended serum:ATCC 30-2020

References: 39920: Isaacs JT, et al. AT3B-1細胞Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 9: 261-281, 1986. PubMed: 3774632

39921: Replogle-Schwab TS, et al. Development of doxorubicin resistant rat prostate cancer cell lines. Anticancer Res. 17: 4535-4538, 1997. PubMed: 9494564

滬公網安備 31011702004356號